SCHEMBL18638158

SCHEMBL18638158

C/N=C\c1nc2ccc(OCCCNC(=O)c3ccc4c(c3)C3(OC4=O)c4ccc(N(C)C)cc4Oc4cc(N(C)C)ccc43)cc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.41
▸ CYP3A4 P08684 1/20 0.35
▸ SCD O00767 1/20 0.34
▸ NT5E P21589 2/20 0.33
▸ MAPT P10636 3/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ITPR3 Q14573 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP8 P22894 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ MIF P14174 1/20 0.32
▸ GSTP1 P09211 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ PI4KB Q9UBF8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13662234 0.87 KCNH2 (0.43) KCNH2CYP3A4SCDNT5EMAPT
SCHEMBL13662226 0.87 KCNH2 (0.43) KCNH2CYP3A4SCDNT5EMAPT
SCHEMBL18116829 0.85 KCNH2 (0.44) KCNH2CYP3A4SCDNT5EMAPT
SCHEMBL18116827 0.79 KCNH2 (0.45) KCNH2CYP3A4NT5EMAPTMEN1
SCHEMBL13662233 0.78 NT5E (0.41) KCNH2CYP3A4NT5EMAPTMEN1
SCHEMBL13663814 0.78 NT5E (0.41) KCNH2CYP3A4NT5EMAPTMEN1
SCHEMBL25457426 0.76 KCNH2 (0.46) KCNH2NT5EMAPTMEN1USP2
SCHEMBL20353098 0.75 KCNH2 (0.44) KCNH2CYP3A4NT5EMAPTMEN1
SCHEMBL18638161 0.75 LMNA (0.36) KCNH2SCDMAPTALDH1A1LMNA
SCHEMBL13637126 0.74 JAK2 (0.41) KCNH2MAPTALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141905-A1 PROTEIN LABELING WITH CYANOBENZOTHIAZOLE CONJUGATES Promega Corporation (US) 2017-03-15 — — EP disclosed
Send feedback